UNRESECTABLE LEIOMYOSARCOMA
Clinical trials for UNRESECTABLE LEIOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE LEIOMYOSARCOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE LEIOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise against rare sarcomas
Disease control OngoingThis study tests whether adding the targeted drug cabozantinib to immunotherapy (ipilimumab and nivolumab) works better than immunotherapy alone for people with advanced soft tissue sarcoma that has spread. About 66 adults with specific sarcoma types will receive either the combo…
Matched conditions: UNRESECTABLE LEIOMYOSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute LAO • Aim: Disease control
Last updated May 26, 2026 04:18 UTC
-
New drug cocktail aims to stall rare sarcomas
Disease control OngoingThis study tests whether combining cabozantinib (a targeted drug) with temozolomide (chemotherapy) can slow or stop tumor growth in people with advanced leiomyosarcoma or other soft tissue sarcomas that cannot be surgically removed or have spread. About 96 participants receive bo…
Matched conditions: UNRESECTABLE LEIOMYOSARCOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 19, 2026 11:55 UTC